In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections
Abstract
The therapeutic challenges caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria have necessitated the development of alternative treatment strategies. Phage-antibiotic synergy (PAS) has recently emerged to replace or possibly supplement antibiotics. We isolated the lytic phage NTNC80A from hospital sewage in Chandigarh, India, and it belongs to the class Caudoviricetes of viruses. We tested multiple strategies to investigate the synergistic effects of phage and antibiotic combinations against highly drug-resistant uropathogenic Escherichia coli isolates. The maximum synergistic effects (ΣFIC ≤0.5) were observed when phage NTNC80A was combined with ciprofloxacin simultaneously. Cell filamentation, characterised by elongated and interconnected cells, was observed at the sub-inhibitory ciprofloxacin doses (1/4,1/10 of MIC). Ciprofloxacin could accelerate cell lysis by stimulating filamentation, disrupting the peptidoglycan layer and enhancing susceptibility to phage enzymes. Phenotypic changes in phage and antibiotic-resistant mutants indicate that bacteria become susceptible to antibiotics or phages when their growth rate, metabolism, or resistance gene expression is altered. The simultaneous strategy outperformed the sequential strategy by enhancing synergistic effects and minimising the risk of resistance development. A significant reduction (p < 0.01-0.001) in bacterial loads in urine, bladder, and kidneys was observed in mice treated with a…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.